[Federal Register Volume 88, Number 218 (Tuesday, November 14, 2023)]
[Notices]
[Page 77952]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24995]



[[Page 77952]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-57-2023]


Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production 
Activity; AIAC International Pharma, LLC; (Pharmaceutical Products); 
Arecibo, Puerto Rico

    AIAC International Pharma, LLC submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Arecibo, Puerto Rico within Subzone 61D. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on November 7, 2023.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished product is Janumet[supreg] XR tablets 
(sitagliptin and metformin hydrochloride extended release) (duty-free).
    The proposed foreign-status material/component is metformin 
hydrochloride active pharmaceutical ingredient (duty-free).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is December 26, 
2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: November 7, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-24995 Filed 11-13-23; 8:45 am]
BILLING CODE 3510-DS-P